The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Strategies to improve radiotherapy with targeted drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Veuger, S. J., Hunter, J. E., & Durkacz, B. W. (2008) · Oncogene · doi:10.1038/onc.2008.439 · Cited by 135
RetractedLynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Genomic instability — an evolving hallmark of cancer
Negrini, S., Gorgoulis, V. G., & Halazonetis, T. D. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2858 · Cited by 2,397
International network of cancer genome projects
The International Cancer Genome Consortium (2010) · Nature · doi:10.1038/nature08987 · Cited by 2,299
Hypoxia in cancer: significance and impact on clinical outcome
Vaupel, P., & Mayer, A. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9055-1 · Cited by 2,240
Drug Resistance and the Solid Tumor Microenvironment
Tredan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm135 · Cited by 2,116 · cited 1×
“Hypoxic cells are often non-dividing and difficult to reach by drugs, also rendering them resistant to many chemotherapeutic agent”
BackgroundBonner, J. A., Harari, P. M., Giralt, J., Cohen, R. B., Jones, C. U., Sur, R. K., Raben, D., Baselga, J., Spencer, S. A., Zhu, J., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70311-0 · Cited by 1,978
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,748
Delaney, G., Jacob, S., Featherstone, C., & Barton, M. (2005) · Cancer · doi:10.1002/cncr.21324 · Cited by 1,727
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
The hazard of accelerated tumor clonogen repopulation during radiotherapy
Withers, H. R., Taylor, J. M. G., & Maciejewski, B. (1988) · Acta Oncologica · doi:10.3109/02841868809090333 · Cited by 1,601
Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis
Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., & Kolesnick, R. (2003) · Science · doi:10.1126/science.1082504 · Cited by 1,593
Gene-Expression Signatures in Breast Cancer
Sotiriou, C., & Pusztai, L. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0801289 · Cited by 1,485
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice
Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., & Kolesnick, R. (2001) · Science · doi:10.1126/science.1060191 · Cited by 1,283
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Hickson, I., Zhao, Y., Richardson, C. J., Green, S. J., Martin, N. M. B., Orr, A. I., Reaper, P. M., Jackson, S. P., Curtin, N. J., & Smith, G. C. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2727 · Cited by 1,220
Hypoxia, DNA repair and genetic instability
Bristow, R. G., & Hill, R. P. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2344 · Cited by 1,140
Bentzen, S. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1950 · Cited by 1,096
Single-strand break repair and genetic disease
Caldecott, K. W. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2380 · Cited by 1,034
Nordsmark, M., Bentzen, S. M., Rudat, V., Brizel, D., Lartigau, E., Stadler, P., Becker, A., Adam, M., Molls, M., Dunst, J., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.038 · Cited by 953
The role of apoptosis in cancer development and treatment response
Brown, J. M., & Attardi, L. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1560 · Cited by 944
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
Spielberger, R., Stiff, P., Bensinger, W., Gentile, T., Weisdorf, D., Kewalramani, T., Shea, T., Yanovich, S., Hansen, K., Noga, S., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040125 · Cited by 893
Rouschop, K. M. A., van den Beucken, T., Dubois, L., Niessen, H., Bussink, J., Savelkouls, K., Keulers, T., Mujcic, H., Landuyt, W., Voncken, J. W., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40027 · Cited by 829
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.003 · Cited by 801
Kioi, M., Vogel, H., Schultz, G., Hoffman, R. M., Harsh, G. R., & Brown, J. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40283 · Cited by 773
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
CDC25 phosphatases in cancer cells: key players? Good targets?
Boutros, R., Lobjois, V., & Ducommun, B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2169 · Cited by 714
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Burdelya, L. G., Krivokrysenko, V. I., Tallant, T. C., Strom, E., Gleiberman, A. S., Gupta, D., Kurnasov, O. V., Fort, F. L., Osterman, A. L., DiDonato, J. A., et al. (2008) · Science · doi:10.1126/science.1154986 · Cited by 705
Repopulation of cancer cells during therapy: an important cause of treatment failure
Kim, J. J., & Tannock, I. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1650 · Cited by 686
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
Martin, M., Lefaix, J.-L., & Delanian, S. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00435-1 · Cited by 657
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Mendes‐Pereira, A. M., Martin, S. A., Brough, R., McCarthy, A., Taylor, J. R., Kim, J., Waldman, T., Lord, C. J., & Ashworth, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900041 · Cited by 638
The impact of a negligent G2/M checkpoint on genomic instability and cancer induction
Löbrich, M., & Jeggo, P. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2248 · Cited by 632
Chi, J.-T., Wang, Z., Nuyten, D. S. A., Rodriguez, E. H., Schaner, M. E., Salim, A., Wang, Y., Kristensen, G. B., Helland, Å., Børresen-Dale, A.-L., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030047 · Cited by 619
MAPK pathways in radiation responses
Dent, P., Yacoub, A., Fisher, P. B., Hagan, M. P., & Grant, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206701 · Cited by 602
Cysteine Protection against X Irradiation
Patt, H. M., Tyree, E. B., Straube, R. L., & Smith, D. E. (1949) · Science · doi:10.1126/science.110.2852.213 · Cited by 599
The role of double-strand break repair — insights from human genetics
O'Driscoll, M., & Jeggo, P. A. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1746 · Cited by 583
Overgaard, J., Sand Hansen, H., Overgaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindeløv, B., & Jørgensen, K. (1998) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(97)00220-x · Cited by 573
Hensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., Cohen, G. I., Emami, B., Gradishar, W. J., Mitchell, R. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2627 · Cited by 540
Dittmann, K., Mayer, C., Fehrenbacher, B., Schaller, M., Raju, U., Milas, L., Chen, D. J., Kehlbach, R., & Rodemann, H. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506591200 · Cited by 529
Calabrese, C. R., Almassy, R., Barton, S., Batey, M. A., Calvert, A. H., Canan-Koch, S., Durkacz, B. W., Hostomsky, Z., Kumpf, R. A., Kyle, S., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh005 · Cited by 487
Rescue of Salivary Gland Function after Stem Cell Transplantation in Irradiated Glands
Lombaert, I. M. A., Brunsting, J. F., Wierenga, P. K., Faber, H., Stokman, M. A., Kok, T., Visser, W. H., Kampinga, H. H., de Haan, G., & Coppes, R. P. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002063 · Cited by 465
Almeida, K. H., & Sobol, R. W. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.01.009 · Cited by 437
Ahn, G.-O., & Brown, J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.11.032 · Cited by 432
Zabludoff, S. D., Deng, C., Grondine, M. R., Sheehy, A. M., Ashwell, S., Caleb, B. L., Green, S., Haye, H. R., Horn, C. L., Janetka, J. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0492 · Cited by 413
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Winter, S. C., Buffa, F. M., Silva, P., Miller, C., Valentine, H. R., Turley, H., Shah, K. A., Cox, G. J., Corbridge, R. J., Homer, J. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3322 · Cited by 410
Li, F., & Sethi, G. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.002 · Cited by 398
Veuger, S. J., Curtin, N. J., Richardson, C. J., Smith, G. C. M., & Durkacz, B. W. (2003) · Cancer Research · doi:10.25405/ncl.34607331 · Cited by 392
Golding, S. E., Rosenberg, E., Valerie, N., Hussaini, I., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L., Menear, K. A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0519 · Cited by 385
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
Rischin, D., Peters, L. J., O'Sullivan, B., Giralt, J., Fisher, R., Yuen, K., Trotti, A., Bernier, J., Bourhis, J., Ringash, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4449 · Cited by 380
Delanian, S., Porcher, R., Balla-Mekias, S., & Lefaix, J.-L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.064 · Cited by 370
Farrell, C. L., Bready, J. V., Rex, K. L., Chen, J. N., DiPalma, C., Whitcomb, K. L., Yin, S., Hill, D. C., Wiemann, B., Starnes, C. O., et al. (1998) · PubMed · Cited by 357
Down-Regulation of Rad51 and Decreased Homologous Recombination in Hypoxic Cancer Cells
Bindra, R. S., Schaffer, P. J., Meng, A., Woo, J., Måseide, K., Roth, M. E., Lizardi, P., Hedley, D. W., Bristow, R. G., & Glazer, P. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8504-8518.2004 · Cited by 356
G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer
Bucher, N., & Britten, C. D. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604208 · Cited by 349
Ahn, G.-O., Tseng, D., Liao, C.-H., Dorie, M. J., Czechowicz, A., & Brown, J. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911378107 · Cited by 347
Gupta, A., McKenna, W. G., Weber, C. N., Feldman, M. D., Goldsmith, J. D., Mick, R., Machtay, M. X., Rosenthal, D. I., Bakanauskas, V. J., Cerniglia, G. J., et al. (2002) · PubMed · Cited by 343
Wouters, B. G., & Brown, J. M. (1997) · Radiation Research · doi:10.2307/3579620 · Cited by 341
Hypoxia-Induced Down-regulation of BRCA1 Expression by E2Fs
Bindra, R. S., Gibson, S. L., Meng, A., Westermark, U., Jasin, M., Pierce, A. J., Bristow, R. G., Classon, M. K., & Glazer, P. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2119 · Cited by 334
FUKS, Z. Y., Persaud, R. S., Alfieri, A. A., McLoughlin, M., Ehleiter, D., Schwartz, J. L., Seddon, A. P., Cordon‐Cardo, C., & Haimovitz‐Friedman, A. (1994) · PubMed · Cited by 331
Chan, N., Koritzinsky, M., Zhao, H., Bindra, R., Glazer, P. M., Powell, S., Belmaaza, A., Wouters, B., & Bristow, R. G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5472 · Cited by 328
Treatment of radiation‐induced nervous system injury with heparin and warfarin
Glantz, M. J., Burger, P. C., Friedman, A. H., Radtke, R. A., Massey, E. W., & Schold, S. C. (1994) · Neurology · doi:10.1212/wnl.44.11.2020 · Cited by 325
(1993) · PubMed · Cited by 323
Delanian, S., Chatel, C., Porcher, R., Depondt, J., & Lefaix, J.-L. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.03.029 · Cited by 322
Enhancement of radiosensitivity by proteasome inhibition: Implications for a role of NF-κB
Russo, S. M., Tepper, J. E., Baldwin, A. S., Liu, R., Adams, J., Elliott, P., & Cusack, J. C. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(01)01446-8 · Cited by 318
Morgan, M. A., Parsels, L. A., Zhao, L., Parsels, J. D., Davis, M. A., Hassan, M. C., Arumugarajah, S., Hylander-Gans, L., Morosini, D., Simeone, D. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3573 · Cited by 303
Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis
Delanian, S., & Lefaix, J.-L. (2007) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2006.11.006 · Cited by 292
Lataillade, J., Doucet, C., Bey, E., Carsin, H., Huet, C., Clairand, I., Bottollier-Depois, J., Chapel, A., Ernou, I., Gourven, M., et al. (2007) · Regenerative Medicine · doi:10.2217/17460751.2.5.785 · Cited by 283
Mukherjee, B., McEllin, B., Camacho, C. V., Tomimatsu, N., Sirasanagandala, S., Nannepaga, S., Hatanpaa, K. J., Mickey, B., Madden, C., Maher, E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4853 · Cited by 270
Rainey, M. D., Charlton, M. E., Stanton, R. V., & Kastan, M. B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0763 · Cited by 266
Albert, J. M., Cao, C., Kim, K. W., Willey, C. D., Geng, L., Xiao, D., Wang, H., Sandler, A., Johnson, D. H., Colevas, A. D., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2872 · Cited by 266
History and development of radiation-protective agents
Weiss, J. F., & Landauer, M. R. (2009) · International Journal of Radiation Biology · doi:10.1080/09553000902985144 · Cited by 258
ARCON: a novel biology-based approach in radiotherapy
Kaanders, J. H., Bussink, J., & van der Kogel, A. J. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00929-4 · Cited by 256
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
Dedes, K. J., Wetterskog, D., Mendes-Pereira, A. M., Natrajan, R., Lambros, M. B., Geyer, F. C., Vatcheva, R., Savage, K., Mackay, A., Lord, C. J., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001538 · Cited by 255
Human AP endonuclease 1 (APE1): From mechanistic insights to druggable target in cancer
Abbotts, R., & Madhusudan, S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.12.006 · Cited by 248
Stone, H. B., Moulder, J. E., Coleman, C. N., Ang, K. K., Anscher, M. S., Barcellos-Hoff, M. H., Dynan, W. S., Fike, J. R., Grdina, D. J., Greenberger, J. S., et al. (2004) · Radiation Research · doi:10.1667/rr3276 · Cited by 246
p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis
Kirsch, D. G., Santiago, P. M., di Tomaso, E., Sullivan, J. M., Hou, W.-S., Dayton, T., Jeffords, L. B., Sodha, P., Mercer, K. L., Cohen, R., et al. (2010) · Science · doi:10.1126/science.1166202 · Cited by 236
McEllin, B., Camacho, C. V., Mukherjee, B., Hahm, B., Tomimatsu, N., Bachoo, R. M., & Burma, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4295 · Cited by 231
Delanian, S., Baillet, F., Huart, J., Lefaix, J.-L., Maulard, C., & Housset, M. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90444-8 · Cited by 230
Dungey, F. A., Löser, D. A., & Chalmers, A. J. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.031 · Cited by 220
Lemée, F., Bergoglio, V., Fernandez-Vidal, A., Machado-Silva, A., Pillaire, M.-J., Bieth, A., Gentil, C., Baker, L., Martin, A.-L., Leduc, C., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910759107 · Cited by 216
Potten, C. S. (2004) · Radiation Research · doi:10.1667/rr3104 · Cited by 212
Toulany, M., Kasten-Pisula, U., Brammer, I., Wang, S., Chen, J., Dittmann, K., Baumann, M., Dikomey, E., & Rodemann, H. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2454 · Cited by 206
Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy
Andreassen, C. N., Grau, C., & Lindegaard, J. C. (2003) · Seminars in Radiation Oncology · doi:10.1053/srao.2003.50006 · Cited by 200
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors
Williamson, C. T., Muzik, H., Turhan, A. G., Zamò, A., O'Connor, M. J., Bebb, D. G., & Lees-Miller, S. P. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0872 · Cited by 193
Vujaskovic, Z., Batinic-Haberle, I., Rabbani, Z. N., Feng, Q.-F., Kang, S. K., Spasojevic, I., Samulski, T. V., Fridovich, I., Dewhirst, M. W., & Anscher, M. S. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00980-2 · Cited by 192
Golding, S. E., Rosenberg, E., Neill, S., Dent, P., Povirk, L. F., & Valerie, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2371 · Cited by 189
DNA Damage Responses: Mechanisms and Roles in Human Disease
Kastan, M. B. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0020 · Cited by 189
West, C., Davidson, S., Roberts, S., & Hunter, R. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.434 · Cited by 185
Sandur, S. K., Deorukhkar, A., Pandey, M. K., Pabón, A. M., Shentu, S., Guha, S., Aggarwal, B. B., & Krishnan, S. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.034 · Cited by 183
Kim, I.-A., Bae, S.-S., Fernandes, A., Wu, J., Muschel, R. J., McKenna, W. G., Birnbaum, M. J., & Bernhard, E. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0513 · Cited by 179
Kennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., De la Vega, M. A., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 175
Komaki, R., Lee, J. S., Milas, L., Lee, H. K., Fossella, F. V., Herbst, R. S., Allen, P. K., Liao, Z., Stevens, C. W., Lu, C., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.10.005 · Cited by 172
Cellular radiosensitivity: How much better do we understand it?
Jeggo, P., & Lavin, M. F. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903261263 · Cited by 168
ATM Activation in Normal Human Tissues and Testicular Cancer
Bártková, J., Bakkenist, C. J., Meyts, E. R., Skakkebæk, N. E., Sehested, M., Lukas, J., Kastan, M. B., & Bártek, J. (2005) · Cell Cycle · doi:10.4161/cc.4.6.1742 · Cited by 163
Ozturk, B., Egehan, Î., Atavci, S., & Kitapci, M. T. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01444-5 · Cited by 159
Recent advances in radiotherapy
Bhide, S., & Nutting, C. M. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-25 · Cited by 158
Kirshner, J., Jobling, M. F., Pajares, M. J., Ravani, S. A., Glick, A. B., Lavin, M. J., Koslov, S., Shiloh, Y., & Barcellos-Hoff, M. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2565 · Cited by 158
Higgins, G. S., Prevo, R., Lee, Y.-F., Helleday, T., Muschel, R. J., Taylor, S., Yoshimura, M., Hickson, I. D., Bernhard, E. J., & McKenna, W. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4040 · Cited by 157
Targeted cancer therapies based on the inhibition of DNA strand break repair
O’Connor, M. J., Martin, N. M. B., & Smith, G. C. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210879 · Cited by 155
Successful treatment of radiation-induced fibrosis using and Mn-SOD: An experimental study
Lefaix, J.-L., Delanian, S. E., Leplat, J. J. J. J., Tricaud, Y., Martin, M. T., Nimrod, A., Baillet, F., & Daburon, F. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(96)00061-2 · Cited by 153
Tumor Vascular Changes Mediated by Inhibition of Oncogenic Signaling
Qayum, N., Muschel, R. J., Im, J. H., Balathasan, L., Koch, C. J., Patel, S. K., McKenna, W. G., & Bernhard, E. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0657 · Cited by 151
Lombaert, I. M. A., Wierenga, P. K., Kok, T., Kampinga, H. H., de Haan, G., & Coppes, R. P. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2381 · Cited by 150
Sémont, A., Mouiseddine, M., François, A., Demarquay, C., Mathieu, N., Chapel, A., Saché, A., Thierry, D., Laloi, P., & Gourmelon, P. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.187 · Cited by 148
Haydont, V., Bourgier, C., Pocard, M. D., Lusinchi, A., Aigueperse, J., Mathé, D., Bourhis, J., & Vozenin, M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0625 · Cited by 147
François, S., Mouiseddine, M., Mathieu, N., Sémont, A., Monti, P., Dudoignon, N., Saché, A., Boutarfa, A., Thierry, D., Gourmelon, P., et al. (2006) · Annals of Hematology · doi:10.1007/s00277-006-0166-5 · Cited by 141
Biologic Properties of Endothelial Progenitor Cells and Their Potential for Cell Therapy
Young, P. P., Vaughan, D. E., & Hatzopoulos, A. K. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.02.004 · Cited by 138
Chalmers, A. J., Lakshman, M., Chan, N. H. L., & Bristow, R. G. (2010) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2010.06.001 · Cited by 137
Bowel injury: current and evolving management strategies
Hauer‐Jensen, M., Wang, J., & Denham, J. W. (2003) · Seminars in Radiation Oncology · doi:10.1016/s1053-4296(03)00032-8 · Cited by 136
Dianov, G. L., O’Neill, P., & GOODHEAD, D. T. (2001) · BioEssays · doi:10.1002/bies.1104 · Cited by 135
Kriegs, M., Kasten-Pisula, U., Rieckmann, T., Holst, K., Saker, J., Dahm‐Daphi, J., & Dikomey, E. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.05.005 · Cited by 134
Stereotactic Ablative Radiotherapy Should Be Combined With a Hypoxic Cell Radiosensitizer
Brown, J. M., Diehn, M., & Loo, B. W. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.04.070 · Cited by 133
Kang, S. K., Rabbani, Z. N., Folz, R. J., Golson, M. L., Huang, H., Yu, D., Samulski, T. V., Dewhirst, M. W., Anscher, M. S., & Vujašković, Ž. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)01369-5 · Cited by 133
Hicks, K. O., Siim, B. G., Jaiswal, J. K., Pruijn, F. B., Fraser, A. M., Patel, R., Hogg, A., Liyanage, H. D. S., Dorie, M. J., Brown, J. M., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1439 · Cited by 132
Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism.
Wouters, B. G., Giaccia, A. J., Denko, N. C., & Brown, J. M. (1997) · PubMed · Cited by 130
CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
Chen, C. C., Kennedy, R. D., Sidi, S., Look, A. T., & D’Andrea, A. D. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-24 · Cited by 129
Noël, G., Godon, C., Fernet, M., Giocanti, N., Mégnin-Chanet, F., & Favaudon, V. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0418 · Cited by 126
Overexpression of POLQ Confers a Poor Prognosis in Early Breast Cancer Patients
Higgins, G. S., Harris, A. L., Prevo, R., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.124 · Cited by 123
Anscher, M. S., Thrasher, B. A., Rabbani, Z. N., Teicher, B. A., & Vujašković, Ž. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.02.051 · Cited by 121
Ahn, G., & Brown, J. M. (2009) · Angiogenesis · doi:10.1007/s10456-009-9135-7 · Cited by 118
Enhancement of Murine Intestinal Stem Cell Survival after Irradiation by Keratinocyte Growth Factor
Khan, W., Shui, C., Ning, S., & Knox, S. J. (1997) · Radiation Research · doi:10.2307/3579609 · Cited by 117
Willers, H., Taghian, A. G., Luo, C., Treszezamsky, A. D., Sgroi, D. C., & Powell, S. N. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0149 · Cited by 117
Zheng, H., Wang, J., Koteliansky, V., Gotwals, P. J., & Hauer‐Jensen, M. (2000) · Gastroenterology · doi:10.1053/gast.2000.19282 · Cited by 114
Regulation of Autophagy Through Multiple Independent Hypoxic Signaling Pathways
Rouschop, K. M. A., & Wouters, B. G. (2009) · Current Molecular Medicine · doi:10.2174/156652409788167131 · Cited by 114
Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1
Simeonov, A. M., Kulkarni, A., Dorjsuren, D. G., Jadhav, A., Shen, M., McNeill, D. R., Austin, C. P., & Wilson, D. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005740 · Cited by 112
Pathogenic role of the renin–angiotensin system in modulating radiation-induced late effects
Robbins, M. E. C., & Diz, D. I. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.08.033 · Cited by 112
Radiobiological considerations in the design of clinical trials
Bentzen, S. M. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90443-x · Cited by 109
Challenges in Using Stem Cells for Cardiac Repair
Mummery, C. L., Davis, R. P., & Krieger, J. E. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000558 · Cited by 108
In Vivo Radioprotective Effects of Angiogenic Growth Factors on the Small Bowel of C3H Mice
Okunieff, P., Mester, M., Wang, J., Maddox, T., Gong, X., Tang, D., Coffee, M. P., & Ding, I. (1998) · Radiation Research · doi:10.2307/3579856 · Cited by 103
Overexpression of extracellular superoxide dismutase reduces acute radiation induced lung toxicity
Rabbani, Z. N., Anscher, M. S., Folz, R. J., Archer, E., Huang, H., Chen, L., Golson, M. L., Samulski, T. V., Dewhirst, M. W., & Vujašković, Ž. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-59 · Cited by 100
Zhao, W., Payne, V. S., Tommasi, E. N., Diz, D. I., Hsu, F., & Robbins, M. E. C. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.036 · Cited by 100
Syljuåsen, R. G., Sørensen, C. S., Nylandsted, J., Lukas, C., Lukas, J., & Bartek, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2434 · Cited by 99
Williams, J. P., Hernady, E., Johnston, C. J., Reed, C., Fenton, B. M., Okunieff, P., & Finkelstein, J. N. (2004) · Radiation Research · doi:10.1667/rr3168 · Cited by 98
Kim, J. H., Brown, S. L., Kolozsvary, A. J. J., Jenrow, K. A., Ryu, S., Rosenblum, M. L., & Carretero, O. A. (2004) · Radiation Research · doi:10.1667/rr3124 · Cited by 98
Antonadou, D., Throuvalas, N., Petridis, A., Bolanos, N., Sagriotis, A., & Synodinou, M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00590-x · Cited by 97
Therapeutic Advantage of Hypoxic Cells in Tumors: A Theoretical Study
Brown, J. M., & Koong, A. C. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.3.178 · Cited by 91
Cytokine Treatment Improves Parenchymal and Vascular Damage of Salivary Glands after Irradiation
Lombaert, I. M. A., Brunsting, J. F., Wierenga, P. K., Kampinga, H. H., de Haan, G., & Coppes, R. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1449 · Cited by 91
Radiation injury and the protein C pathway
Hauer‐Jensen, M., Fink, L. M., & Wang, J. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000126358.15697.75 · Cited by 82
Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
Nitta, M., Kozono, D., Kennedy, R. D., Stommel, J. M., Ng, K., Zinn, P. O., Kushwaha, D. S., Kesari, S., Furnari, F. B., Hoadley, K. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010767 · Cited by 82
Cohen, E. P., Irving, A. A., Drobyski, W. R., Klein, J. P., Passweg, J. R., Talano, J., Juckett, M., & Moulder, J. E. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.08.041 · Cited by 81
Wang, J., Boerma, M., Fu, Q., Kulkarni, A., Fink, L. M., & Hauer‐Jensen, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.036 · Cited by 77
Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation
Khandelwal, S. R., Randad, R. S., Lin, P., Meng, H., Pittman, R. N., Kontos, H. A., Choi, S. C., Abraham, D. J., & Schmidt‐Ullrich, R. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.4.h1450 · Cited by 76
Scott, C., Suh, J. H., Stea, B., Nabid, A., & Hackman, J. (2007) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3180653c0d · Cited by 75
Impact of supervised gene signatures of early hypoxia on patient survival
Seigneuric, R., Starmans, M. H. W., Fung, G., Krishnapuram, B., Nuyten, D. S. A., van Erk, A., Magagnin, M. G., Rouschop, K. M. A., Krishnan, S., Rao, R. B., et al. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.002 · Cited by 74
Self-citationVerheij, M., Vens, C., & van Triest, B. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.01.002 · Cited by 74
Self-citationThe farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras.
Moyal, E. C., Evans, S. M., Koch, C. J., Muschel, R. J., McKenna, W. G., Wu, J., & Bernhard, E. J. (2001) · PubMed · Cited by 70
New rationales for using TGFbetainhibitors in radiotherapy
Andarawewa, K. L., Paupert, J., Pal, A., & Barcellos‐Hoff, M. H. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701711063 · Cited by 66
Can Angiotensin-Converting Enzyme Inhibitors Protect against Symptomatic Radiation Pneumonitis?
Wang, L. W., Fu, X., Clough, R. W., Sibley, G. S., Fan, M., Bentel, G. C., Marks, L. B., & Anscher, M. S. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)153[0405:caceip]2.0.co;2 · Cited by 65
Zhang, X., Epperly, M. W., Kay, M. A., Chen, Z.-Y., Dixon, T. M., Franicola, D., Greenberger, B. A., Komanduri, P., & Greenberger, J. S. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.141 · Cited by 62
Wang, J., Zheng, H., Ou, X., Albertson, C., Fink, L. M., Herbert, J., & Hauer‐Jensen, M. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2004.00960.x · Cited by 61
Moulder, J. E., Fish, B. L., & Cohen, E. P. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207780618821 · Cited by 60
Chen, L., Brizel, D. M., Rabbani, Z. N., Samulski, T. V., Farrell, C. L., Larrier, N., Anscher, M. S., & Vujašković, Ž. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.07.729 · Cited by 56
Jenner, T. J., Fulford, J., & O'Neill, P. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)156[0590:cobltr]2.0.co;2 · Cited by 54
Feng, F. Y.-C., Lopez, C. A., Normolle, D. P., Varambally, S., Li, X., Chun, P. Y., Davis, M. A., Lawrence, T. S., & Nyati, M. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2582 · Cited by 53
Tsuboi, Y., Kurimoto, M., Nagai, S., Hayakawa, Y., Kamiyama, H., Hayashi, N., Kitajima, I., & Endo, S. (2008) · Journal of neurosurgery · doi:10.3171/2008.8.jns17648 · Cited by 52
Wang, J., Albertson, C., Zheng, H., Fink, L. M., Herbert, J., & Hauer‐Jensen, M. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612954 · Cited by 52
Stem Cell Therapy to Reduce Radiation-Induced Normal Tissue Damage
Coppes, R. P., van der Goot, A., & Lombaert, I. M. A. (2009) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2008.11.005 · Cited by 52
No Significant Endothelial Apoptosis in the Radiation-Induced Gastrointestinal Syndrome
Schuller, B. W., Rogers, A. B., Cormier, K. S., Riley, K. J., Binns, P. J., Julius, R. L., Hawthorne, M. F., & Coderre, J. A. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.12.069 · Cited by 50
Wiegman, E. M., Bläse, M., Loeffler, H., Coppes, R. P., & Rodemann, H. P. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.013 · Cited by 50
Radioprotection of mouse skin by WR-2721: The critical influence of oxygen tension
Denekamp, J., Michael, B. D., Rojas, A., & Stewart, F. A. (1982) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(82)90677-0 · Cited by 49
Self-citationModification of Radiation Myelopathy by the Transplantation of Neural Stem Cells in the Rat
Rezvani, M., Birds, D. A., Hodges, H. R., Hopewell, J. W., Milledew, K., & Wilkinson, J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)156[0408:mormbt]2.0.co;2 · Cited by 47
Endothelial Progenitor Cells: A Promising Therapeutic Alternative for Cardiovascular Disease
Dong, C., & Goldschmidt‐Clermont, P. J. (2007) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.2007.00251.x · Cited by 43
Ahn, G., & Brown, J. M. (2009) · Cell Cycle · doi:10.4161/cc.8.7.8075 · Cited by 41
Krause, M., Gurtner, K., Deuse, Y., & Baumann, M. A. (2009) · International Journal of Radiation Biology · doi:10.3109/09553000903232835 · Cited by 38
Díez, P., Vogelius, I. R., & Bentzen, S. M. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.06.013 · Cited by 36
Amelioration of Radiation Nephropathy by Acetylsalicylic Acid
Verheij, M., Stewart, F. A., Oussoren, Y. G., Weening, J. J., & Dewit, L. G. H. (1995) · International Journal of Radiation Biology · doi:10.1080/09553009514550701 · Cited by 35
Self-citationTargeted Radiosensitization of Cells Expressing Truncated DNA Polymerase β
Neijenhuis, S., Verwijs-Janssen, M., van den Broek, L. J., Begg, A. C., & Vens, C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3901 · Cited by 34
Self-citationTee, P. G., & Travis, E. L. (1995) · PubMed · Cited by 30
CDC25 Inhibitors as Anticancer Agents Are Moving Forward
Brézak, M.-C., Kasprzyk, P. G., Contour-Galcéra, M.-O., Lavergne, O., & Prevost, G. P. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008786847701 · Cited by 19
Enhancement of Radiation Cytotoxicity by UCN-01 in Non-small Cell Lung Carcinoma Cells
Mack, P. C., Jones, A. A., Gustafsson, M. H., Gandara, D. R., Gumerlock, P. H., & Goldberg, Z. (2004) · Radiation Research · doi:10.1667/rr3253 · Cited by 15
Cited by
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
Deng, L., Liang, H., Xu, M., Yang, X., Burnette, B., Arina, A., Li, X.-D., Mauceri, H., Beckett, M., Darga, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.019 · Cited by 2,182
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144
Targeting the DNA Damage Response in Cancer
O’Connor, M. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.040 · Cited by 1,518
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R.-X., & Zhou, P.-K. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,198
Metadata
- Authors
- Begg, A. C., Stewart, F. A., & Vens, C.
- Venue
- Nature Reviews Cancer
- Published
- 2011-03-24
- Volume
- 11
- Issue
- 4
- Pages
- 239-253
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2003601710
- Cited by
- 1,118
- References
- 181
- FWCI
- 10.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.